Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 July 2022 | Story Lacea Loader

The Council of the University of the Free State (UFS) approved the lifting of the institution’s COVID-19 Regulations and Required Vaccination Policy with immediate effect.

“Since the declaration by the Government on 22 June 2022 that the COVID-19 regulations will be repealed, the UFS has conducted a risk assessment to determine the risk of exposure to staff and students. From the assessment, it was clear that the university’s COVID-19 infections are currently a low risk,” said Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.

Factors that contributed to this low risk include the following:

  • No COVID-19 positive cases among UFS staff and students have been reported in the past month.
  • The high number of vaccinations among UFS stakeholders. In addition, the current national immunity level of the total South African population is high.
  • Certain faculties and postgraduate students are currently proceeding with hybrid/online learning, which minimises the risk of possible COVID-19 infections on the university’s three campuses.
  • In its correspondence of 23 June 2022, the UFS urged all staff and students to continue wearing masks should they have comorbidities and/or symptoms of illness, thus safeguarding other stakeholders.

“We believe that COVID-19 no longer poses an immediate threat to the safety of our staff and students, and that the pandemic is at a stage where they should take responsibility for their own safety. This can be mainly ascribed to the success of the implementation of the policy. Staff and students who still wish to wear masks are urged to do so at their own discretion. Those who have not yet been vaccinated against the virus and have no

known condition preventing them from doing so, are advised to get vaccinated for their own safety and protection,” said Prof Petersen.

The UFS COVID-19 Regulations and Required Vaccination Policy was approved by the University Council on 26 November 2021 and implemented on 6 December 2021. The university commenced restricting unvaccinated individuals from accessing its campuses as of 14 February 2022.

“If the national regulatory environment with respect to COVID-19 is changing to such an extent that the policy needs to be re-implemented, the university’s executive management will act accordingly, and hence the COVID-19 Regulations and Required Vaccination Policy remains a policy of the university as approved by the UFS Council on 26 November 2021.” said Prof Petersen.

 

Uplifting of the COVID-19 vaccination policy - mitigation strategies of the University of the Free State.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept